Showing results (181-190 of 224) with videos related to
Sort By:
Pageof 23
Investigational New Drugs|May 26, 2016
Pharmacokinetics and excretion of (14)C-omacetaxine in patients with advanced solid tumorsCynthia M Nijenhuis, Edward Hellriegel, Jos H Beijnen, et al.Clinical Pharmacology and Therapeutics|May 16, 2002
Population pharmacokinetic and adverse event analysis of topotecan in patients with solid tumorsDiane R Mould, Nicholas H G Holford, Jan H M Schellens, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2015
Upfront Genotyping of DPYD*2A to Individualize Fluoropyrimidine Therapy: A Safety and Cost AnalysisMaarten J Deenen, Didier Meulendijks, Annemieke Cats, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 26, 2022
Overestimation of the effect of (fos)aprepitant on intravenous dexamethasone pharmacokinetics requires adaptation of the guidelines for children with chemotherapy-induced nausea and vomitingA Laura Nijstad, Evelien de Vos-Kerkhof, Catherine F Enters-Weijnen, et al.Cancers|November 27, 2021
Intra-Tumoral Pharmacokinetics of Pazopanib in Combination with Radiotherapy in Patients with Non-Metastatic Soft-Tissue SarcomaLaura Molenaar-Kuijsten, Milan van Meekeren, Remy B Verheijen, et al.Molecular Pharmacology|December 17, 2013
Bcrp1;Mdr1a/b;Mrp2 combination knockout mice: altered disposition of the dietary carcinogen PhIP (2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine) and its genotoxic metabolitesMaria L H Vlaming, Sebastiaan F Teunissen, Evita van de Steeg, et al.Clinical Pharmacokinetics|February 6, 2020
Cost-Neutral Optimization of Pazopanib Exposure by Splitting Intake Moments: A Prospective Pharmacokinetic Study in Cancer PatientsStefanie L Groenland, Ruben A G van Eerden, Remy B Verheijen, et al.Acta Pharmacologica Sinica|November 4, 2024
Intestinal human carboxylesterase 2 (CES2) expression rescues drug metabolism and most metabolic syndrome phenotypes in global Ces2 cluster knockout miceYao-Geng Wang, Chang-Pei Gan, Joke Beukers-Korver, et al.Proceedings of the National Academy of Sciences of the United States of America|November 14, 2002
The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyriaJohan W Jonker, Marije Buitelaar, Els Wagenaar, et al.The Oncologist|December 9, 2020
Phase I Study of Afatinib and Selumetinib in Patients with KRAS-Mutated Colorectal, Non-Small Cell Lung, and Pancreatic CancerEmilie M J van Brummelen, Sanne Huijberts, Carla van Herpen, et al.Pageof 23